'Quell' is a pain-relieving wearable that works to eliminate chronic pains in the body. The Quell is worn on your upper calf, with the electrode in direct contact to your skin. Quell stimulates the nerves in the upper calf, which then carries neural pulses to the portion of the brain responsible for pain relief response.
To cater to each individual, Quell has a quick and easy calibration setup that customizes to the individual wearing it. Quell uses technology called OptiTherapy to ensure that each user gets the right amount of pain relief. Users can also track their therapy and sleep sessions through a Bluetooth-connected app.
In the US alone, 100 million people suffer from chronic pain and are unable to find a long-lasting solution. Quell is attempting to change that statistic and also offer a drug-free alternative as the world's first pain-relieving wearable.
What's Driving This Trend
- Pain-relieving Wearables
- Disruptive Innovation Opportunity: Develop advanced wearables that leverage technology to effectively reduce chronic pain for individuals.
- Optitherapy Technology
- Disruptive Innovation Opportunity: Explore the development of personalized pain relief technologies that use advanced algorithms to deliver optimal pain relief to individuals.
- Drug-free Alternatives
- Disruptive Innovation Opportunity: Create innovative non-pharmaceutical solutions for pain management to provide individuals with effective alternatives to traditional medications.
Who This Affects Most
- Healthcare
- Disruptive Innovation Opportunity: Integrate wearable technology into healthcare industry practices to revolutionize pain management and enhance patient outcomes.
- Wearable Technology
- Disruptive Innovation Opportunity: Expand the application of wearable technology to address health-related issues and offer personalized pain relief solutions.
- Wellness and Fitness
- Disruptive Innovation Opportunity: Merge pain relief technology with wellness and fitness industries to improve overall well-being and recovery for individuals.
